查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1193237

消化健康市場：按類型、形式和分銷渠道分類：2021-2031 年全球機遇分析和行業預測

Digestive Health Market By Type, By Form, By Distribution Channel : Global Opportunity Analysis and Industry Forecast, 2021-2031
出版日期: | 出版商: Allied Market Research | 英文 310 Pages | 商品交期: 2-3個工作天內

價格

全球消化健康市場預計到 2021 年將達到 387.8913 億美元，到 2031 年將達到 902.567 億美元，從 2022 年到 2031 年的複合年增長率為 8.8%。

消化系統健康是人們最關心的問題之一。 不健康的腸道會極大地影響人類的整體健康，為了避免這種情況，我們需要營養素來確保正常的消化功能並從我們的飲食中獲得最大益處。它包括從生物素到消化酶的各種產品。 它們促進健康的身體機能，幫助控制從口腔到胃部的致病微生物。 此外，適量使用益生菌補充劑可以幫助消化過程並改善營養吸收。

根據國家生物技術信息中心 (NCBI) 的數據，據估計，消化系統疾病每年影響美國 60 至 7000 萬人，而結直腸癌是美國男性和女性中最常見的癌症之一。是診斷出的第二大常見癌症類型 因此，消化系統疾病的患病率在世界範圍內不斷增加，進一步增加了對消化保健產品的需求。

此外，消化健康市場的增長受到製藥和膳食補充劑公司推出的眾多產品改進、對治療慢性消化系統疾病的解決方案的需求增加以及易於獲取的推動。提供範圍廣泛的價格合理且具有成本效益的產品和補充劑。

此外，隨著 "腸道健康是體重管理的關鍵" 這一日益增長的趨勢，益生元製造商正在努力跟上全球對益生元不斷增長的需求。 研究人員發現，有助於腸道消化和營養吸收的腸道細菌會影響減肥能力，導致注重體重的人群和市場對益生元的需求增加，從而推動增長。

缺乏運動和健身活動，公眾對健康營養的興趣日益濃厚，消費者對促進消化健康的益生菌的投資不斷增加，對功能性食品的偏好越來越多因此，個人的消化問題越來越多，隨著新產品的推出推動市場增長. 另一方面，主要市場參與者增加研發計劃為市場增長提供了有利可圖的機會。

雖然有多種因素推動市場增長，但也有一些限制因素影響市場，例如嚴格的政府法規和與製造過程相關的高開發成本。 例如，2002 年的公共衛生安全和生物恐怖主義準備和應對法案（Bioterrorism Act）要求膳食補充劑公司向 FDA 註冊，並向 FDA 提供足夠的信息以便在緊急情況下與公司聯繫，公司有義務這樣做。

內容

第一章介紹

第 2 章執行摘要

第 3 章市場概述

  • 市場定義和範圍
  • 主要發現
    • 主要投資領域
  • 波特的五力分析
  • 主要公司的定位
  • 市場動態
    • 司機
    • 約束因素
    • 機會
  • COVID-19 影響分析
  • 專利情況

第 4 章消化健康市場，按類型

  • 概覽
    • 市場規模和預測
  • 益生元
    • 主要市場趨勢、增長因素和機遇
    • 市場規模和預測：按地區
    • 市場分析：按國家/地區分類
  • 益生菌
    • 主要市場趨勢、增長因素和機遇
    • 市場規模和預測：按地區
    • 市場分析：按國家/地區分類
  • 消化酶
    • 主要市場趨勢、增長動力和機遇
    • 市場規模和預測：按地區
    • 市場分析：按國家/地區分類

第 5 章消化健康市場：按類型

  • 概覽
    • 市場規模和預測
  • 膠囊
    • 主要市場趨勢、增長因素和機遇
    • 市場規模和預測：按地區
    • 市場分析：按國家/地區分類
  • 藥片
    • 主要市場趨勢、增長因素和機遇
    • 市場規模和預測：按地區
    • 市場分析：按國家/地區分類
  • 其他
    • 主要市場趨勢、增長因素和機遇
    • 市場規模和預測：按地區
    • 市場分析：按國家/地區分類

第 6 章消化健康市場：按分銷渠道

  • 概覽
    • 市場規模和預測
  • 藥店、零售藥店
    • 主要市場趨勢、增長因素和機遇
    • 市場規模和預測：按地區
    • 市場分析：按國家/地區分類
    • 藥店和藥房的胃腸保健市場：按類型分類
      • 處方藥市場規模和預測：按地區
      • OTC 市場規模趨勢和預測：按地區
  • 在線提供商
    • 主要市場趨勢、增長因素和機遇
    • 各地區的市場規模和預測
    • 市場分析：按國家/地區分類
  • 其他
    • 主要市場趨勢、增長因素和機遇
    • 市場規模和預測：按地區
    • 市場分析：按國家/地區分類

第 7 章消化健康市場：按地區

  • 概覽
    • 市場規模和預測
  • 北美
    • 主要趨勢和機遇
    • 北美市場規模和預測：按類型
    • 北美市場規模和預測：按類型
    • 北美市場規模和預測：按分銷渠道
      • 北美藥店和零售藥店消化健康市場：按類型分類
    • 北美市場規模和預測：按國家/地區分類
      • 美國
      • 加拿大
      • 墨西哥
  • 歐洲
    • 主要趨勢和機遇
    • 歐洲市場規模和預測：按類型
    • 歐洲市場規模和預測：按類型
    • 歐洲市場規模和預測：按分銷渠道
      • 歐洲藥店和零售藥店消化健康市場：按類型分類
    • 歐洲市場規模和預測：按國家/地區分類
      • 德國
      • 法國
      • 英國
      • 意大利
      • 西班牙
      • 其他歐洲
  • 亞太地區
    • 主要趨勢和機遇
    • 亞太市場規模和預測：按類型
    • 亞太地區的市場規模和預測：按類型
    • 亞太市場規模和預測：按分銷渠道
      • 亞太地區藥店和零售藥店消化健康市場，按類型
    • 亞太地區的市場規模和預測：按國家/地區分類
      • 日本
      • 中國
      • 澳大利亞
      • 印度
      • 韓國
      • 其他亞太地區
  • 拉美
    • 主要趨勢和機遇
    • LAMEA 市場規模和預測：按類型
    • LAMEA 市場規模和預測：按類型
    • LAMEA 市場規模和預測：按分銷渠道
      • LAMEA 藥店和零售藥店消化健康市場：按類型分類
    • LAMEA 市場規模和預測：按國家/地區分類
      • 巴西
      • 沙特阿拉伯
      • 南非
      • LAMEA 的其餘部分

第八章公司情況

  • 簡介
  • 關鍵成功策略
  • 10 家主要公司的產品映射
  • 比賽儀表板
  • 競爭熱圖
  • 主要發展

第九章公司簡介

  • Bayer AG
  • GalaxoSmithKline PLC
  • Pfizer Inc.
  • Sanofi
  • Nestle SA
  • Herbalife Nutrition Ltd.
  • BASF SE
  • NOW Health Group Inc.
  • Amway Corporation
  • The Bountiful Company（Nature's Bounty）
Product Code: A31458

The global digestive health market was valued at $38,789.13 million in 2021, and is projected to reach $90,205.67 million by 2031, registering a CAGR of 8.8% from 2022 to 2031.

Digestive health is one of the main concerns that everyone talks about every day. The overall health of a person can be greatly impacted by an unhealthy gut and thus, to avoid the same, the body needs nutrients to ensure normal digestive function and to maximize the benefits from their diet, which includes a wide range of products from probiotics to digestive enzymes. These promote healthy body function and assist in management of pathogenic microbes from the mouth to stomach. In addition, probiotics supplements assist in digestion process and enhance nutrient absorption when used in proper amount.

According to the National Center for Biotechnology Information (NCBI), gastrointestinal diseases affect an estimated 60 to 70 million people annually in America, with colorectal cancer as the 2nd leading cancer type diagnosed among American men and women. Thus, there is a growing prevalence of digestive diseases around the globe, which further propels the need for digestive health products.

Furthermore, growth of the digestive health market is anticipated to be facilitated by introduction of numerous advancements in products by the pharmaceutical and nutraceutical companies, increase in demand for solutions to treat chronic digestive diseases, and availability of wide range of products and supplements that are easily accessible and cost-effective.

Moreover, with growth in trend of "Gut Health-Key of Weight Management," prebiotics manufacturers are scrambling to keep up with the rising demand for prebiotics globally. Researchers discovered that the bacteria in the gut, which aid in digestion and absorption of nutrients in intestines, can affect capacity to lose weight, thus leading to rise in demand for prebiotics among weight conscious population and propelling the market growth.

Rse in digestive issues among individuals, owing to lack of sports and fitness activities, growing focus of the population on healthy nutrition, and rise in investments by consumers in probiotics for digestive health and rising preference for functional foods, along with new product launches, propel the market growth. Whereas, increase in R&D initiatives by key market players provide lucrative opportunities for growth of the market.

Although, there are various factors that propel the market growth, there are few restraints that affect the market including stringent government regulations and high development cost associated with the manufacturing process. For instance, the Public Health Security and Bioterrorism Preparedness and Response Act of 2002 (the Bioterrorism Act) requires dietary supplement companies to register with FDA and provide FDA with sufficient information to contact companies in an emergency.

The digestive health market is segmented on the basis of product, form, distribution channel, and region. By product, it is divided into prebiotics, probiotics, and digestive enzymes. On the basis of type, it is segmented into capsules, tablets, and others. By distribution channel, it is segmented into drug stores & retail pharmacies, online providers, and others (supermarkets/hypermarkets).  The drug stores & retail pharmacies segment is further divided into prescription and OTC (over-the-counter). Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

The major companies profiled in this report include Amway Corporation, Bayer AG, BASF SE, GlaxoSmithKline PLC, Herbalife Nutrition Ltd., Nestle SA, NOW Health Group Inc., Pfizer Inc., Sanofi, and the Bountiful Company (Nature's Bounty).

Key Benefits For Stakeholders

  • This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the digestive health market analysis from 2021 to 2031 to identify the prevailing digestive health market opportunities.
  • The market research is offered along with information related to key drivers, restraints, and opportunities.
  • Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
  • In-depth analysis of the digestive health market segmentation assists to determine the prevailing market opportunities.
  • Major countries in each region are mapped according to their revenue contribution to the global market.
  • Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
  • The report includes the analysis of the regional as well as global digestive health market trends, key players, market segments, application areas, and market growth strategies.

Key Market Segments

By Type

  • Prebiotics
  • Probiotics
  • Digestive Enzymes

By Form

  • Capsule
  • Tablet
  • Others

By Distribution Channel

  • Drug Stores and Retail Pharmacies
    • Type
    • Prescription
    • OTC
  • Online Providers
  • Others

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest Of Europe
  • Asia-Pacific
    • Japan
    • China
    • Australia
    • India
    • South Korea
    • Rest Of Asia-Pacific
  • LAMEA
    • Brazil
    • Saudi Arabia
    • South Africa
    • Rest Of LAMEA
  • Key Market Players
    • Bayer AG
    • GalaxoSmithKline PLC
    • Pfizer Inc.
    • Sanofi
    • Nestle SA
    • Herbalife Nutrition Ltd.
    • BASF SE
    • NOW Health Group Inc.
    • Amway Corporation
    • The Bountiful Company (Nature's Bounty)

TABLE OF CONTENTS

CHAPTER 1:INTRODUCTION

  • 1.1.Report description
  • 1.2.Key market segments
  • 1.3.Key benefits to the stakeholders
  • 1.4.Research Methodology
    • 1.4.1.Secondary research
    • 1.4.2.Primary research
    • 1.4.3.Analyst tools and models

CHAPTER 2:EXECUTIVE SUMMARY

  • 2.1.Key findings of the study
  • 2.2.CXO Perspective

CHAPTER 3:MARKET OVERVIEW

  • 3.1.Market definition and scope
  • 3.2.Key findings
    • 3.2.1.Top investment pockets
  • 3.3.Porter's five forces analysis
  • 3.4.Top player positioning
  • 3.5.Market dynamics
    • 3.5.1.Drivers
    • 3.5.2.Restraints
    • 3.5.3.Opportunities
  • 3.6.COVID-19 Impact Analysis on the market
  • 3.7.Patent Landscape

CHAPTER 4: DIGESTIVE HEALTH MARKET, BY TYPE

  • 4.1 Overview
    • 4.1.1 Market size and forecast
  • 4.2 Prebiotics
    • 4.2.1 Key market trends, growth factors and opportunities
    • 4.2.2 Market size and forecast, by region
    • 4.2.3 Market analysis by country
  • 4.3 Probiotics
    • 4.3.1 Key market trends, growth factors and opportunities
    • 4.3.2 Market size and forecast, by region
    • 4.3.3 Market analysis by country
  • 4.4 Digestive Enzymes
    • 4.4.1 Key market trends, growth factors and opportunities
    • 4.4.2 Market size and forecast, by region
    • 4.4.3 Market analysis by country

CHAPTER 5: DIGESTIVE HEALTH MARKET, BY FORM

  • 5.1 Overview
    • 5.1.1 Market size and forecast
  • 5.2 Capsule
    • 5.2.1 Key market trends, growth factors and opportunities
    • 5.2.2 Market size and forecast, by region
    • 5.2.3 Market analysis by country
  • 5.3 Tablet
    • 5.3.1 Key market trends, growth factors and opportunities
    • 5.3.2 Market size and forecast, by region
    • 5.3.3 Market analysis by country
  • 5.4 Others
    • 5.4.1 Key market trends, growth factors and opportunities
    • 5.4.2 Market size and forecast, by region
    • 5.4.3 Market analysis by country

CHAPTER 6: DIGESTIVE HEALTH MARKET, BY DISTRIBUTION CHANNEL

  • 6.1 Overview
    • 6.1.1 Market size and forecast
  • 6.2 Drug Stores and Retail Pharmacies
    • 6.2.1 Key market trends, growth factors and opportunities
    • 6.2.2 Market size and forecast, by region
    • 6.2.3 Market analysis by country
    • 6.2.4 Drug Stores and Retail Pharmacies Digestive Health Market by Type
      • 6.2.4.1 Prescription Market size and forecast, by region
      • 6.2.4.2 OTC Market size and forecast, by region
  • 6.3 Online Providers
    • 6.3.1 Key market trends, growth factors and opportunities
    • 6.3.2 Market size and forecast, by region
    • 6.3.3 Market analysis by country
  • 6.4 Others
    • 6.4.1 Key market trends, growth factors and opportunities
    • 6.4.2 Market size and forecast, by region
    • 6.4.3 Market analysis by country

CHAPTER 7: DIGESTIVE HEALTH MARKET, BY REGION

  • 7.1 Overview
    • 7.1.1 Market size and forecast
  • 7.2 North America
    • 7.2.1 Key trends and opportunities
    • 7.2.2 North America Market size and forecast, by Type
    • 7.2.3 North America Market size and forecast, by Form
    • 7.2.4 North America Market size and forecast, by Distribution Channel
      • 7.2.4.1 North America Drug Stores and Retail Pharmacies Digestive Health Market by Type
    • 7.2.5 North America Market size and forecast, by country
      • 7.2.5.1 U.S.
      • 7.2.5.1.1 Market size and forecast, by Type
      • 7.2.5.1.2 Market size and forecast, by Form
      • 7.2.5.1.3 Market size and forecast, by Distribution Channel
      • 7.2.5.2 Canada
      • 7.2.5.2.1 Market size and forecast, by Type
      • 7.2.5.2.2 Market size and forecast, by Form
      • 7.2.5.2.3 Market size and forecast, by Distribution Channel
      • 7.2.5.3 Mexico
      • 7.2.5.3.1 Market size and forecast, by Type
      • 7.2.5.3.2 Market size and forecast, by Form
      • 7.2.5.3.3 Market size and forecast, by Distribution Channel
  • 7.3 Europe
    • 7.3.1 Key trends and opportunities
    • 7.3.2 Europe Market size and forecast, by Type
    • 7.3.3 Europe Market size and forecast, by Form
    • 7.3.4 Europe Market size and forecast, by Distribution Channel
      • 7.3.4.1 Europe Drug Stores and Retail Pharmacies Digestive Health Market by Type
    • 7.3.5 Europe Market size and forecast, by country
      • 7.3.5.1 Germany
      • 7.3.5.1.1 Market size and forecast, by Type
      • 7.3.5.1.2 Market size and forecast, by Form
      • 7.3.5.1.3 Market size and forecast, by Distribution Channel
      • 7.3.5.2 France
      • 7.3.5.2.1 Market size and forecast, by Type
      • 7.3.5.2.2 Market size and forecast, by Form
      • 7.3.5.2.3 Market size and forecast, by Distribution Channel
      • 7.3.5.3 UK
      • 7.3.5.3.1 Market size and forecast, by Type
      • 7.3.5.3.2 Market size and forecast, by Form
      • 7.3.5.3.3 Market size and forecast, by Distribution Channel
      • 7.3.5.4 Italy
      • 7.3.5.4.1 Market size and forecast, by Type
      • 7.3.5.4.2 Market size and forecast, by Form
      • 7.3.5.4.3 Market size and forecast, by Distribution Channel
      • 7.3.5.5 Spain
      • 7.3.5.5.1 Market size and forecast, by Type
      • 7.3.5.5.2 Market size and forecast, by Form
      • 7.3.5.5.3 Market size and forecast, by Distribution Channel
      • 7.3.5.6 Rest of Europe
      • 7.3.5.6.1 Market size and forecast, by Type
      • 7.3.5.6.2 Market size and forecast, by Form
      • 7.3.5.6.3 Market size and forecast, by Distribution Channel
  • 7.4 Asia-Pacific
    • 7.4.1 Key trends and opportunities
    • 7.4.2 Asia-Pacific Market size and forecast, by Type
    • 7.4.3 Asia-Pacific Market size and forecast, by Form
    • 7.4.4 Asia-Pacific Market size and forecast, by Distribution Channel
      • 7.4.4.1 Asia-Pacific Drug Stores and Retail Pharmacies Digestive Health Market by Type
    • 7.4.5 Asia-Pacific Market size and forecast, by country
      • 7.4.5.1 Japan
      • 7.4.5.1.1 Market size and forecast, by Type
      • 7.4.5.1.2 Market size and forecast, by Form
      • 7.4.5.1.3 Market size and forecast, by Distribution Channel
      • 7.4.5.2 China
      • 7.4.5.2.1 Market size and forecast, by Type
      • 7.4.5.2.2 Market size and forecast, by Form
      • 7.4.5.2.3 Market size and forecast, by Distribution Channel
      • 7.4.5.3 Australia
      • 7.4.5.3.1 Market size and forecast, by Type
      • 7.4.5.3.2 Market size and forecast, by Form
      • 7.4.5.3.3 Market size and forecast, by Distribution Channel
      • 7.4.5.4 India
      • 7.4.5.4.1 Market size and forecast, by Type
      • 7.4.5.4.2 Market size and forecast, by Form
      • 7.4.5.4.3 Market size and forecast, by Distribution Channel
      • 7.4.5.5 South Korea
      • 7.4.5.5.1 Market size and forecast, by Type
      • 7.4.5.5.2 Market size and forecast, by Form
      • 7.4.5.5.3 Market size and forecast, by Distribution Channel
      • 7.4.5.6 Rest of Asia-Pacific
      • 7.4.5.6.1 Market size and forecast, by Type
      • 7.4.5.6.2 Market size and forecast, by Form
      • 7.4.5.6.3 Market size and forecast, by Distribution Channel
  • 7.5 LAMEA
    • 7.5.1 Key trends and opportunities
    • 7.5.2 LAMEA Market size and forecast, by Type
    • 7.5.3 LAMEA Market size and forecast, by Form
    • 7.5.4 LAMEA Market size and forecast, by Distribution Channel
      • 7.5.4.1 LAMEA Drug Stores and Retail Pharmacies Digestive Health Market by Type
    • 7.5.5 LAMEA Market size and forecast, by country
      • 7.5.5.1 Brazil
      • 7.5.5.1.1 Market size and forecast, by Type
      • 7.5.5.1.2 Market size and forecast, by Form
      • 7.5.5.1.3 Market size and forecast, by Distribution Channel
      • 7.5.5.2 Saudi Arabia
      • 7.5.5.2.1 Market size and forecast, by Type
      • 7.5.5.2.2 Market size and forecast, by Form
      • 7.5.5.2.3 Market size and forecast, by Distribution Channel
      • 7.5.5.3 South Africa
      • 7.5.5.3.1 Market size and forecast, by Type
      • 7.5.5.3.2 Market size and forecast, by Form
      • 7.5.5.3.3 Market size and forecast, by Distribution Channel
      • 7.5.5.4 Rest of LAMEA
      • 7.5.5.4.1 Market size and forecast, by Type
      • 7.5.5.4.2 Market size and forecast, by Form
      • 7.5.5.4.3 Market size and forecast, by Distribution Channel

CHAPTER 8: COMPANY LANDSCAPE

  • 8.1. Introduction
  • 8.2. Top winning strategies
  • 8.3. Product Mapping of Top 10 Player
  • 8.4. Competitive Dashboard
  • 8.5. Competitive Heatmap
  • 8.6. Key developments

CHAPTER 9: COMPANY PROFILES

  • 9.1 Bayer AG
    • 9.1.1 Company overview
    • 9.1.2 Company snapshot
    • 9.1.3 Operating business segments
    • 9.1.4 Product portfolio
    • 9.1.5 Business performance
    • 9.1.6 Key strategic moves and developments
  • 9.2 GalaxoSmithKline PLC
    • 9.2.1 Company overview
    • 9.2.2 Company snapshot
    • 9.2.3 Operating business segments
    • 9.2.4 Product portfolio
    • 9.2.5 Business performance
    • 9.2.6 Key strategic moves and developments
  • 9.3 Pfizer Inc.
    • 9.3.1 Company overview
    • 9.3.2 Company snapshot
    • 9.3.3 Operating business segments
    • 9.3.4 Product portfolio
    • 9.3.5 Business performance
    • 9.3.6 Key strategic moves and developments
  • 9.4 Sanofi
    • 9.4.1 Company overview
    • 9.4.2 Company snapshot
    • 9.4.3 Operating business segments
    • 9.4.4 Product portfolio
    • 9.4.5 Business performance
    • 9.4.6 Key strategic moves and developments
  • 9.5 Nestle SA
    • 9.5.1 Company overview
    • 9.5.2 Company snapshot
    • 9.5.3 Operating business segments
    • 9.5.4 Product portfolio
    • 9.5.5 Business performance
    • 9.5.6 Key strategic moves and developments
  • 9.6 Herbalife Nutrition Ltd.
    • 9.6.1 Company overview
    • 9.6.2 Company snapshot
    • 9.6.3 Operating business segments
    • 9.6.4 Product portfolio
    • 9.6.5 Business performance
    • 9.6.6 Key strategic moves and developments
  • 9.7 BASF SE
    • 9.7.1 Company overview
    • 9.7.2 Company snapshot
    • 9.7.3 Operating business segments
    • 9.7.4 Product portfolio
    • 9.7.5 Business performance
    • 9.7.6 Key strategic moves and developments
  • 9.8 NOW Health Group Inc.
    • 9.8.1 Company overview
    • 9.8.2 Company snapshot
    • 9.8.3 Operating business segments
    • 9.8.4 Product portfolio
    • 9.8.5 Business performance
    • 9.8.6 Key strategic moves and developments
  • 9.9 Amway Corporation
    • 9.9.1 Company overview
    • 9.9.2 Company snapshot
    • 9.9.3 Operating business segments
    • 9.9.4 Product portfolio
    • 9.9.5 Business performance
    • 9.9.6 Key strategic moves and developments
  • 9.10 The Bountiful Company (Nature's Bounty)
    • 9.10.1 Company overview
    • 9.10.2 Company snapshot
    • 9.10.3 Operating business segments
    • 9.10.4 Product portfolio
    • 9.10.5 Business performance
    • 9.10.6 Key strategic moves and developments

LIST OF TABLES

  • TABLE 1. GLOBAL DIGESTIVE HEALTH MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 2. DIGESTIVE HEALTH MARKET, FOR PREBIOTICS, BY REGION, 2021-2031 ($MILLION)
  • TABLE 3. DIGESTIVE HEALTH MARKET FOR PREBIOTICS, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 4. DIGESTIVE HEALTH MARKET, FOR PROBIOTICS, BY REGION, 2021-2031 ($MILLION)
  • TABLE 5. DIGESTIVE HEALTH MARKET FOR PROBIOTICS, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 6. DIGESTIVE HEALTH MARKET, FOR DIGESTIVE ENZYMES, BY REGION, 2021-2031 ($MILLION)
  • TABLE 7. DIGESTIVE HEALTH MARKET FOR DIGESTIVE ENZYMES, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 8. GLOBAL DIGESTIVE HEALTH MARKET, BY FORM, 2021-2031 ($MILLION)
  • TABLE 9. DIGESTIVE HEALTH MARKET, FOR CAPSULE, BY REGION, 2021-2031 ($MILLION)
  • TABLE 10. DIGESTIVE HEALTH MARKET FOR CAPSULE, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 11. DIGESTIVE HEALTH MARKET, FOR TABLET, BY REGION, 2021-2031 ($MILLION)
  • TABLE 12. DIGESTIVE HEALTH MARKET FOR TABLET, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 13. DIGESTIVE HEALTH MARKET, FOR OTHERS, BY REGION, 2021-2031 ($MILLION)
  • TABLE 14. DIGESTIVE HEALTH MARKET FOR OTHERS, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 15. GLOBAL DIGESTIVE HEALTH MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
  • TABLE 16. DIGESTIVE HEALTH MARKET, FOR DRUG STORES AND RETAIL PHARMACIES, BY REGION, 2021-2031 ($MILLION)
  • TABLE 17. DIGESTIVE HEALTH MARKET FOR DRUG STORES AND RETAIL PHARMACIES, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 18. GLOBAL DRUG STORES AND RETAIL PHARMACIES DIGESTIVE HEALTH MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 19. DIGESTIVE HEALTH MARKET, FOR PRESCRIPTION, BY REGION, 2021-2031 ($MILLION)
  • TABLE 20. DIGESTIVE HEALTH MARKET, FOR OTC, BY REGION, 2021-2031 ($MILLION)
  • TABLE 21. DIGESTIVE HEALTH MARKET, FOR ONLINE PROVIDERS, BY REGION, 2021-2031 ($MILLION)
  • TABLE 22. DIGESTIVE HEALTH MARKET FOR ONLINE PROVIDERS, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 23. DIGESTIVE HEALTH MARKET, FOR OTHERS, BY REGION, 2021-2031 ($MILLION)
  • TABLE 24. DIGESTIVE HEALTH MARKET FOR OTHERS, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 25. DIGESTIVE HEALTH MARKET, BY REGION, 2021-2031 ($MILLION)
  • TABLE 26. NORTH AMERICA DIGESTIVE HEALTH MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 27. NORTH AMERICA DIGESTIVE HEALTH MARKET, BY FORM, 2021-2031 ($MILLION)
  • TABLE 28. NORTH AMERICA DIGESTIVE HEALTH MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
  • TABLE 29. NORTH AMERICA DRUG STORES AND RETAIL PHARMACIES DIGESTIVE HEALTH MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 30. NORTH AMERICA DIGESTIVE HEALTH MARKET, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 31. U.S. DIGESTIVE HEALTH MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 32. U.S. DIGESTIVE HEALTH MARKET, BY FORM, 2021-2031 ($MILLION)
  • TABLE 33. U.S. DIGESTIVE HEALTH MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
  • TABLE 34. CANADA DIGESTIVE HEALTH MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 35. CANADA DIGESTIVE HEALTH MARKET, BY FORM, 2021-2031 ($MILLION)
  • TABLE 36. CANADA DIGESTIVE HEALTH MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
  • TABLE 37. MEXICO DIGESTIVE HEALTH MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 38. MEXICO DIGESTIVE HEALTH MARKET, BY FORM, 2021-2031 ($MILLION)
  • TABLE 39. MEXICO DIGESTIVE HEALTH MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
  • TABLE 40. EUROPE DIGESTIVE HEALTH MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 41. EUROPE DIGESTIVE HEALTH MARKET, BY FORM, 2021-2031 ($MILLION)
  • TABLE 42. EUROPE DIGESTIVE HEALTH MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
  • TABLE 43. EUROPE DRUG STORES AND RETAIL PHARMACIES DIGESTIVE HEALTH MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 44. EUROPE DIGESTIVE HEALTH MARKET, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 45. GERMANY DIGESTIVE HEALTH MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 46. GERMANY DIGESTIVE HEALTH MARKET, BY FORM, 2021-2031 ($MILLION)
  • TABLE 47. GERMANY DIGESTIVE HEALTH MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
  • TABLE 48. FRANCE DIGESTIVE HEALTH MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 49. FRANCE DIGESTIVE HEALTH MARKET, BY FORM, 2021-2031 ($MILLION)
  • TABLE 50. FRANCE DIGESTIVE HEALTH MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
  • TABLE 51. UK DIGESTIVE HEALTH MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 52. UK DIGESTIVE HEALTH MARKET, BY FORM, 2021-2031 ($MILLION)
  • TABLE 53. UK DIGESTIVE HEALTH MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
  • TABLE 54. ITALY DIGESTIVE HEALTH MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 55. ITALY DIGESTIVE HEALTH MARKET, BY FORM, 2021-2031 ($MILLION)
  • TABLE 56. ITALY DIGESTIVE HEALTH MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
  • TABLE 57. SPAIN DIGESTIVE HEALTH MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 58. SPAIN DIGESTIVE HEALTH MARKET, BY FORM, 2021-2031 ($MILLION)
  • TABLE 59. SPAIN DIGESTIVE HEALTH MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
  • TABLE 60. REST OF EUROPE DIGESTIVE HEALTH MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 61. REST OF EUROPE DIGESTIVE HEALTH MARKET, BY FORM, 2021-2031 ($MILLION)
  • TABLE 62. REST OF EUROPE DIGESTIVE HEALTH MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
  • TABLE 63. ASIA-PACIFIC DIGESTIVE HEALTH MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 64. ASIA-PACIFIC DIGESTIVE HEALTH MARKET, BY FORM, 2021-2031 ($MILLION)
  • TABLE 65. ASIA-PACIFIC DIGESTIVE HEALTH MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
  • TABLE 66. ASIA-PACIFIC DRUG STORES AND RETAIL PHARMACIES DIGESTIVE HEALTH MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 67. ASIA-PACIFIC DIGESTIVE HEALTH MARKET, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 68. JAPAN DIGESTIVE HEALTH MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 69. JAPAN DIGESTIVE HEALTH MARKET, BY FORM, 2021-2031 ($MILLION)
  • TABLE 70. JAPAN DIGESTIVE HEALTH MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
  • TABLE 71. CHINA DIGESTIVE HEALTH MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 72. CHINA DIGESTIVE HEALTH MARKET, BY FORM, 2021-2031 ($MILLION)
  • TABLE 73. CHINA DIGESTIVE HEALTH MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
  • TABLE 74. AUSTRALIA DIGESTIVE HEALTH MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 75. AUSTRALIA DIGESTIVE HEALTH MARKET, BY FORM, 2021-2031 ($MILLION)
  • TABLE 76. AUSTRALIA DIGESTIVE HEALTH MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
  • TABLE 77. INDIA DIGESTIVE HEALTH MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 78. INDIA DIGESTIVE HEALTH MARKET, BY FORM, 2021-2031 ($MILLION)
  • TABLE 79. INDIA DIGESTIVE HEALTH MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
  • TABLE 80. SOUTH KOREA DIGESTIVE HEALTH MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 81. SOUTH KOREA DIGESTIVE HEALTH MARKET, BY FORM, 2021-2031 ($MILLION)
  • TABLE 82. SOUTH KOREA DIGESTIVE HEALTH MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
  • TABLE 83. REST OF ASIA-PACIFIC DIGESTIVE HEALTH MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 84. REST OF ASIA-PACIFIC DIGESTIVE HEALTH MARKET, BY FORM, 2021-2031 ($MILLION)
  • TABLE 85. REST OF ASIA-PACIFIC DIGESTIVE HEALTH MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
  • TABLE 86. LAMEA DIGESTIVE HEALTH MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 87. LAMEA DIGESTIVE HEALTH MARKET, BY FORM, 2021-2031 ($MILLION)
  • TABLE 88. LAMEA DIGESTIVE HEALTH MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
  • TABLE 89. LAMEA DRUG STORES AND RETAIL PHARMACIES DIGESTIVE HEALTH MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 90. LAMEA DIGESTIVE HEALTH MARKET, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 91. BRAZIL DIGESTIVE HEALTH MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 92. BRAZIL DIGESTIVE HEALTH MARKET, BY FORM, 2021-2031 ($MILLION)
  • TABLE 93. BRAZIL DIGESTIVE HEALTH MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
  • TABLE 94. SAUDI ARABIA DIGESTIVE HEALTH MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 95. SAUDI ARABIA DIGESTIVE HEALTH MARKET, BY FORM, 2021-2031 ($MILLION)
  • TABLE 96. SAUDI ARABIA DIGESTIVE HEALTH MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
  • TABLE 97. SOUTH AFRICA DIGESTIVE HEALTH MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 98. SOUTH AFRICA DIGESTIVE HEALTH MARKET, BY FORM, 2021-2031 ($MILLION)
  • TABLE 99. SOUTH AFRICA DIGESTIVE HEALTH MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
  • TABLE 100. REST OF LAMEA DIGESTIVE HEALTH MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 101. REST OF LAMEA DIGESTIVE HEALTH MARKET, BY FORM, 2021-2031 ($MILLION)
  • TABLE 102. REST OF LAMEA DIGESTIVE HEALTH MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
  • TABLE 103.BAYER AG: COMPANY SNAPSHOT
  • TABLE 104.BAYER AG: OPERATING SEGMENTS
  • TABLE 105.BAYER AG: PRODUCT PORTFOLIO
  • TABLE 106.BAYER AG: NET SALES,
  • TABLE 107.BAYER AG: KEY STRATERGIES
  • TABLE 108.GALAXOSMITHKLINE PLC: COMPANY SNAPSHOT
  • TABLE 109.GALAXOSMITHKLINE PLC: OPERATING SEGMENTS
  • TABLE 110.GALAXOSMITHKLINE PLC: PRODUCT PORTFOLIO
  • TABLE 111.GALAXOSMITHKLINE PLC: NET SALES,
  • TABLE 112.GALAXOSMITHKLINE PLC: KEY STRATERGIES
  • TABLE 113.PFIZER INC.: COMPANY SNAPSHOT
  • TABLE 114.PFIZER INC.: OPERATING SEGMENTS
  • TABLE 115.PFIZER INC.: PRODUCT PORTFOLIO
  • TABLE 116.PFIZER INC.: NET SALES,
  • TABLE 117.PFIZER INC.: KEY STRATERGIES
  • TABLE 118.SANOFI: COMPANY SNAPSHOT
  • TABLE 119.SANOFI: OPERATING SEGMENTS
  • TABLE 120.SANOFI: PRODUCT PORTFOLIO
  • TABLE 121.SANOFI: NET SALES,
  • TABLE 122.SANOFI: KEY STRATERGIES
  • TABLE 123.NESTLE SA: COMPANY SNAPSHOT
  • TABLE 124.NESTLE SA: OPERATING SEGMENTS
  • TABLE 125.NESTLE SA: PRODUCT PORTFOLIO
  • TABLE 126.NESTLE SA: NET SALES,
  • TABLE 127.NESTLE SA: KEY STRATERGIES
  • TABLE 128.HERBALIFE NUTRITION LTD.: COMPANY SNAPSHOT
  • TABLE 129.HERBALIFE NUTRITION LTD.: OPERATING SEGMENTS
  • TABLE 130.HERBALIFE NUTRITION LTD.: PRODUCT PORTFOLIO
  • TABLE 131.HERBALIFE NUTRITION LTD.: NET SALES,
  • TABLE 132.HERBALIFE NUTRITION LTD.: KEY STRATERGIES
  • TABLE 133.BASF SE: COMPANY SNAPSHOT
  • TABLE 134.BASF SE: OPERATING SEGMENTS
  • TABLE 135.BASF SE: PRODUCT PORTFOLIO
  • TABLE 136.BASF SE: NET SALES,
  • TABLE 137.BASF SE: KEY STRATERGIES
  • TABLE 138.NOW HEALTH GROUP INC.: COMPANY SNAPSHOT
  • TABLE 139.NOW HEALTH GROUP INC.: OPERATING SEGMENTS
  • TABLE 140.NOW HEALTH GROUP INC.: PRODUCT PORTFOLIO
  • TABLE 141.NOW HEALTH GROUP INC.: NET SALES,
  • TABLE 142.NOW HEALTH GROUP INC.: KEY STRATERGIES
  • TABLE 143.AMWAY CORPORATION: COMPANY SNAPSHOT
  • TABLE 144.AMWAY CORPORATION: OPERATING SEGMENTS
  • TABLE 145.AMWAY CORPORATION: PRODUCT PORTFOLIO
  • TABLE 146.AMWAY CORPORATION: NET SALES,
  • TABLE 147.AMWAY CORPORATION: KEY STRATERGIES
  • TABLE 148.THE BOUNTIFUL COMPANY (NATURE'S BOUNTY): COMPANY SNAPSHOT
  • TABLE 149.THE BOUNTIFUL COMPANY (NATURE'S BOUNTY): OPERATING SEGMENTS
  • TABLE 150.THE BOUNTIFUL COMPANY (NATURE'S BOUNTY): PRODUCT PORTFOLIO
  • TABLE 151.THE BOUNTIFUL COMPANY (NATURE'S BOUNTY): NET SALES,
  • TABLE 152.THE BOUNTIFUL COMPANY (NATURE'S BOUNTY): KEY STRATERGIES

LIST OF FIGURES

  • FIGURE 1.DIGESTIVE HEALTH MARKET SEGMENTATION
  • FIGURE 2.DIGESTIVE HEALTH MARKET,2021-2031
  • FIGURE 3.DIGESTIVE HEALTH MARKET,2021-2031
  • FIGURE 4. TOP INVESTMENT POCKETS, BY REGION
  • FIGURE 5.PORTER FIVE-1
  • FIGURE 6.PORTER FIVE-2
  • FIGURE 7.PORTER FIVE-3
  • FIGURE 8.PORTER FIVE-4
  • FIGURE 9.PORTER FIVE-5
  • FIGURE 10.TOP PLAYER POSITIONING
  • FIGURE 11.DIGESTIVE HEALTH MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES
  • FIGURE 12.PATENT ANALYSIS BY COMPANY
  • FIGURE 13.PATENT ANALYSIS BY COUNTRY
  • FIGURE 14.DIGESTIVE HEALTH MARKET,BY TYPE,2021(%)
  • FIGURE 15.COMPARATIVE SHARE ANALYSIS OF PREBIOTICS DIGESTIVE HEALTH MARKET,2021-2031(%)
  • FIGURE 16.COMPARATIVE SHARE ANALYSIS OF PROBIOTICS DIGESTIVE HEALTH MARKET,2021-2031(%)
  • FIGURE 17.COMPARATIVE SHARE ANALYSIS OF DIGESTIVE ENZYMES DIGESTIVE HEALTH MARKET,2021-2031(%)
  • FIGURE 18.DIGESTIVE HEALTH MARKET,BY FORM,2021(%)
  • FIGURE 19.COMPARATIVE SHARE ANALYSIS OF CAPSULE DIGESTIVE HEALTH MARKET,2021-2031(%)
  • FIGURE 20.COMPARATIVE SHARE ANALYSIS OF TABLET DIGESTIVE HEALTH MARKET,2021-2031(%)
  • FIGURE 21.COMPARATIVE SHARE ANALYSIS OF OTHERS DIGESTIVE HEALTH MARKET,2021-2031(%)
  • FIGURE 22.DIGESTIVE HEALTH MARKET,BY DISTRIBUTION CHANNEL,2021(%)
  • FIGURE 23.COMPARATIVE SHARE ANALYSIS OF DRUG STORES AND RETAIL PHARMACIES DIGESTIVE HEALTH MARKET,2021-2031(%)
  • FIGURE 24.COMPARATIVE SHARE ANALYSIS OF ONLINE PROVIDERS DIGESTIVE HEALTH MARKET,2021-2031(%)
  • FIGURE 25.COMPARATIVE SHARE ANALYSIS OF OTHERS DIGESTIVE HEALTH MARKET,2021-2031(%)
  • FIGURE 26.DIGESTIVE HEALTH MARKET BY REGION,2021
  • FIGURE 27.U.S. DIGESTIVE HEALTH MARKET,2021-2031($MILLION)
  • FIGURE 28.CANADA DIGESTIVE HEALTH MARKET,2021-2031($MILLION)
  • FIGURE 29.MEXICO DIGESTIVE HEALTH MARKET,2021-2031($MILLION)
  • FIGURE 30.GERMANY DIGESTIVE HEALTH MARKET,2021-2031($MILLION)
  • FIGURE 31.FRANCE DIGESTIVE HEALTH MARKET,2021-2031($MILLION)
  • FIGURE 32.UK DIGESTIVE HEALTH MARKET,2021-2031($MILLION)
  • FIGURE 33.ITALY DIGESTIVE HEALTH MARKET,2021-2031($MILLION)
  • FIGURE 34.SPAIN DIGESTIVE HEALTH MARKET,2021-2031($MILLION)
  • FIGURE 35.REST OF EUROPE DIGESTIVE HEALTH MARKET,2021-2031($MILLION)
  • FIGURE 36.JAPAN DIGESTIVE HEALTH MARKET,2021-2031($MILLION)
  • FIGURE 37.CHINA DIGESTIVE HEALTH MARKET,2021-2031($MILLION)
  • FIGURE 38.AUSTRALIA DIGESTIVE HEALTH MARKET,2021-2031($MILLION)
  • FIGURE 39.INDIA DIGESTIVE HEALTH MARKET,2021-2031($MILLION)
  • FIGURE 40.SOUTH KOREA DIGESTIVE HEALTH MARKET,2021-2031($MILLION)
  • FIGURE 41.REST OF ASIA-PACIFIC DIGESTIVE HEALTH MARKET,2021-2031($MILLION)
  • FIGURE 42.BRAZIL DIGESTIVE HEALTH MARKET,2021-2031($MILLION)
  • FIGURE 43.SAUDI ARABIA DIGESTIVE HEALTH MARKET,2021-2031($MILLION)
  • FIGURE 44.SOUTH AFRICA DIGESTIVE HEALTH MARKET,2021-2031($MILLION)
  • FIGURE 45.REST OF LAMEA DIGESTIVE HEALTH MARKET,2021-2031($MILLION)
  • FIGURE 46. TOP WINNING STRATEGIES, BY YEAR
  • FIGURE 47. TOP WINNING STRATEGIES, BY DEVELOPMENT
  • FIGURE 48. TOP WINNING STRATEGIES, BY COMPANY
  • FIGURE 49.PRODUCT MAPPING OF TOP 10 PLAYERS
  • FIGURE 50.COMPETITIVE DASHBOARD
  • FIGURE 51.COMPETITIVE HEATMAP OF TOP 10 KEY PLAYERS
  • FIGURE 52.BAYER AG.: NET SALES ,($MILLION)
  • FIGURE 53.GALAXOSMITHKLINE PLC.: NET SALES ,($MILLION)
  • FIGURE 54.PFIZER INC..: NET SALES ,($MILLION)
  • FIGURE 55.SANOFI.: NET SALES ,($MILLION)
  • FIGURE 56.NESTLE SA.: NET SALES ,($MILLION)
  • FIGURE 57.HERBALIFE NUTRITION LTD..: NET SALES ,($MILLION)
  • FIGURE 58.BASF SE.: NET SALES ,($MILLION)
  • FIGURE 59.NOW HEALTH GROUP INC..: NET SALES ,($MILLION)
  • FIGURE 60.AMWAY CORPORATION.: NET SALES ,($MILLION)
  • FIGURE 61.THE BOUNTIFUL COMPANY (NATURE'S BOUNTY).: NET SALES ,($MILLION)